Featured Research

from universities, journals, and other organizations

End your child’s allergy suffering within three years? Immunotherapy can provide long-term relief, study shows

Date:
October 1, 2012
Source:
American College of Allergy, Asthma and Immunology (ACAAI)
Summary:
When children suffer from dust mite induced allergies and asthma, finding relief can seem impossible. While there isn't a complete cure for childhood respiratory allergies, researchers have found that long term control of allergic asthma can occur after only three years of allergy shots.

When children suffer from dust mite induced allergies and asthma, finding relief can seem impossible. While there isn't a complete cure for childhood respiratory allergies, researchers have found that long term control of allergic asthma can occur after only three years of allergy shots.

Related Articles


According to a new study, published in the October issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), long-term relief can be achieved by administering immunotherapy for three years.

"The recommended duration of immunotherapy for long-term effectiveness has been three to five years," said Iwona Stelmach, MD, PhD, lead study author. "Our research shows that three years is an adequate duration for the treatment of childhood asthma associated with house dust mites. An additional two years adds no clinical benefit."

Immunotherapy, also known as allergy shots, can alter the progression of allergic disease. The treatment alleviates patients of symptoms, while preventing asthma and the development of other allergies. The study also found that 50 percent of children with asthma due to dust mites experienced remission after three years of treatment with greatly reduced or no controller medications need at that point.

"It has long been observed that the effectiveness of allergy shots continue long after treatment has been completed," said allergist James Sublett, MD, chair of the ACAAI Indoor Environment Committee. "This study is among the first to look at the benefits of different lengths of therapy. Not only does immunotherapy provide long-term therapeutic benefits for both children and adults, it can reduce total healthcare costs by 33 to 41 percent."

High levels of exposure to dust mites are a factor in the development of asthma in children. Allergic children react to proteins within the bodies and feces of the mites. These particles are found mostly in pillows, mattresses, carpeting, stuffed animals and upholstered furniture. There may be as many as 19,000 dust mites in one gram of dust.

Mites eat particles of skin and dander, so they thrive in places where there are people and animals. This can make relieving symptoms particularly difficult without the use of immunotherapy.

Allergists are specialists in administering allergy shots. To locate an allergist in your area and to find relief, visit www.AllergyAndAsthmaRelief.org.


Story Source:

The above story is based on materials provided by American College of Allergy, Asthma and Immunology (ACAAI). Note: Materials may be edited for content and length.


Journal Reference:

  1. Iwona Stelmach, Agnieszka Sobocińska, Paweł Majak, Katarzyna Smejda, Joanna Jerzyńska, Włodzimierz Stelmach. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Annals of Allergy, Asthma & Immunology, 2012; 109 (4): 274 DOI: 10.1016/j.anai.2012.07.015

Cite This Page:

American College of Allergy, Asthma and Immunology (ACAAI). "End your child’s allergy suffering within three years? Immunotherapy can provide long-term relief, study shows." ScienceDaily. ScienceDaily, 1 October 2012. <www.sciencedaily.com/releases/2012/10/121001083330.htm>.
American College of Allergy, Asthma and Immunology (ACAAI). (2012, October 1). End your child’s allergy suffering within three years? Immunotherapy can provide long-term relief, study shows. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2012/10/121001083330.htm
American College of Allergy, Asthma and Immunology (ACAAI). "End your child’s allergy suffering within three years? Immunotherapy can provide long-term relief, study shows." ScienceDaily. www.sciencedaily.com/releases/2012/10/121001083330.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins